Johnson & Johnson
JNJ
$167.30
$0.310.19%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 10/01/2023 | 07/02/2023 | |
|---|---|---|---|---|---|
| Revenue | 86.58B | 85.65B | 85.16B | 83.70B | 82.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 86.58B | 85.65B | 85.16B | 83.70B | 82.35B |
| Cost of Revenue | 26.47B | 26.06B | 26.04B | 25.41B | 25.21B |
| Gross Profit | 60.11B | 59.59B | 59.12B | 58.29B | 57.14B |
| SG&A Expenses | 21.05B | 20.64B | 20.16B | 19.74B | 19.32B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.42B | 61.87B | 61.29B | 59.47B | 58.88B |
| Operating Income | 24.16B | 23.78B | 23.87B | 24.24B | 23.47B |
| Income Before Tax | 19.51B | 20.06B | 15.06B | 14.08B | 14.03B |
| Income Tax Expenses | 3.12B | 2.99B | 1.74B | 1.66B | 1.61B |
| Earnings from Continuing Operations | 16.38K | 17.07K | 13.33K | 12.42K | 12.42K |
| Earnings from Discontinued Operations | 21.64B | 21.40B | 21.83B | 22.20B | 632.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.02B | 38.48B | 35.15B | 34.62B | 13.05B |
| EBIT | 24.16B | 23.78B | 23.87B | 24.24B | 23.47B |
| EBITDA | 31.04B | 30.82B | 30.97B | 31.01B | 30.10B |
| EPS Basic | 15.08 | 15.11 | 13.73 | 13.62 | 5.00 |
| Normalized Basic EPS | 6.32 | 6.07 | 5.90 | 6.28 | 6.01 |
| EPS Diluted | 14.94 | 14.97 | 13.60 | 13.46 | 4.93 |
| Normalized Diluted EPS | 6.28 | 6.02 | 5.87 | 6.23 | 5.96 |
| Average Basic Shares Outstanding | 10.10B | 10.30B | 10.49B | 10.35B | 10.46B |
| Average Diluted Shares Outstanding | 10.17B | 10.37B | 10.55B | 10.44B | 10.56B |
| Dividend Per Share | 4.81 | 4.76 | 4.70 | 4.64 | 4.58 |
| Payout Ratio | 22.93% | 22.94% | 25.32% | 25.96% | 91.60% |
